Literature DB >> 11073750

Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome.

J H Weitkamp1, Y W Tang, D W Haas, N K Midha, J E Crowe.   

Abstract

Achromobacter xylosoxidans (formerly Alcaligenes xylosoxidans) is a rare but important cause of bacteremia in immunocompromised patients, and strains are usually multiply resistant to antimicrobial therapy. We report an immunocompromised patient with hyper-immunoglobulin M syndrome who suffered from 14 documented episodes of A. xylosoxidans bacteremia. Each episode was treated and resulted in rapid clinical improvement, with blood cultures testing negative for bacteria. Between episodes, A. xylosoxidans was isolated from an excised right axillary lymph node, whereas the culture of the central venous catheter, removed at the same time, was negative. Multiple cultures from sputum, stool, and urine samples, as well as from gastrointestinal biopsies or environmental sources, were negative. Results from antibiotic sensitivity testing and pulsed-field gel electrophoresis suggested that a single strain of A. xylosoxidans caused the recurrent bacteremias in this patient; this strain originated from persistently infected lymph nodes. Lymphoid hyperplasia is a prominent characteristic of hyper-IgM syndrome and may serve as a source of bacteremia with low-pathogenicity organisms.

Entities:  

Mesh:

Year:  2000        PMID: 11073750     DOI: 10.1086/317461

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  Cloning, overexpression, and characterization of a novel thermostable penicillin G acylase from Achromobacter xylosoxidans: probing the molecular basis for its high thermostability.

Authors:  Gang Cai; Songcheng Zhu; Sheng Yang; Guoping Zhao; Weihong Jiang
Journal:  Appl Environ Microbiol       Date:  2004-05       Impact factor: 4.792

2.  [(3)H]Adenine is a suitable radioligand for the labeling of G protein-coupled adenine receptors but shows high affinity to bacterial contaminations in buffer solutions.

Authors:  Anke C Schiedel; Heiko Meyer; Bernt B A Alsdorf; Simone Gorzalka; Hannelore Brüssel; Christa E Müller
Journal:  Purinergic Signal       Date:  2007-07-25       Impact factor: 3.765

3.  A rare cause of peritoneal dialysis-related peritonitis: Achromobacter denitrificans.

Authors:  E Cankaya; M Keles; E Gulcan; A Uyanik; H Uyanik
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

Review 4.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients.

Authors:  Lixia Liu; Tom Coenye; Jane L Burns; Paul W Whitby; Terrence L Stull; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

6.  Achromobacter xylosoxidans infection presenting as a pulmonary nodule mimicking cancer.

Authors:  Stephanie L Claassen; Jason M Reese; Vincent Mysliwiec; Steven D Mahlen
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

7.  Triclosan-resistant bacteria isolated from feedlot and residential soils.

Authors:  Tanner T Welsch; Eric T Gillock
Journal:  J Environ Sci Health A Tox Hazard Subst Environ Eng       Date:  2011       Impact factor: 2.269

8.  Achromobacter xylosoxidans keratitis after contact lens usage.

Authors:  Jung Hyun Park; Nang Hee Song; Jae Woong Koh
Journal:  Korean J Ophthalmol       Date:  2012-01-14

9.  Got black swimming dots in your cell culture? Identification of Achromobacter as a novel cell culture contaminant.

Authors:  Jennifer Sue Gray; Janette Marie Birmingham; Jenifer Imig Fenton
Journal:  Biologicals       Date:  2009-11-18       Impact factor: 1.856

10.  Epidemiological typing of clinical isolates of Achromobacter xylosoxidans: comparison of phenotypic and genotypic methods.

Authors:  M Kaur; P Ray; M Bhatty; M Sharma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-17       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.